BECN1 and hepatocellular carcinoma: In the current study, normal pattern expression of Beclin-1 was detected in all adjacent non tumorous tissue (100%), with negative expression in 18/50 (36%) and over-expression in 16/50 (32%) of investigated HCC cases.